The role of chitotriosidase duplication gene polymorphism in the susceptibility to sarcoidosis
Abstract
Background: Sarcoidosis is a systemic granulomatous disease that most commonly affects respiratory system, and may present with an acute onset or follow a chronic course. Sarcoidosis has an established genetic component, supported by evidence from familial, population and linkage genetic studies. Several attempts at discerning the exact genetic background of sarcoidosis have produced mostly inconclusive results. Recently, the roles of fungal infection and exposure to fungal antigens have been implicated in sarcoidosis pathogenesis. A mammalian form of chitinolytic enzyme – chitotriosidase has been discovered, and it has been hypothesised to play a role in defense against chitin-containing pathogens and innate immunity. A 24 base pair duplication polymorphism in the chitotriosidase gene (CHIT1) has been described, causing abnormal mRNA splicing patterns, leading to enzymatically inactive chitotriosidase. Methods: An association study has been performed, comparing frequencies of duplication polymorphism in groups of 159 Slovenian patients with sarcoidosis and 272 healthy controls. Genotyping was performed by polymerase chain reaction (PCR), followed by size discrimination of PCR products with agarose gel electrophoresis. Statistical analyses have been performed using Pearson’s Chi-Square test. Results: Our results did not show significant association of 24bp duplication polymorphism in CHIT1 gene with the susceptibility to sarcoidosis. Conclusions: In our study, we were unable to demonstrate a significant effect of duplication polymorphic variation in the CHIT1 gene on the susceptibility to sarcoidosis. However, other polymorphisms in CHIT1 gene should be investigated and additional studies performed in other genetically distinct populations.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.